Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04058483 · ClinicalTrials.gov registry record · NA

Validating the New Remote Hypnotic Induction Profile (rHIP)

A NA study of Testing the Hypnotizability of Healthy Volunteers, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04058483: Completed NA study of Testing the Hypnotizability of Healthy Volunteers, sponsored by Stanford University.

NCT04058483 is a NA study of Testing the Hypnotizability of Healthy Volunteers that has completed, run by Stanford University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04058483, a NA study of Testing the Hypnotizability of Healthy Volunteers, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine if hypnotizability can be reliably tested over the phone, without having to see or touch a patient. The scores from a new test for hypnotizability by phone will be compared to the scores from a standard in-person test, to make sure the results are similar.

Primary Outcome

Calculate the correlation between the HIP and rHIP

Interventions

  • OTHER Hypnotizability testing

Study Locations (1)

California

  • Stanford University/Stanford Healthcare - Palo Alto

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2019-09-13
Est. Completion 2019-10-14
Phase NA
Stanford University

1,744 total trials

What the finished NCT04058483 record still lists

NCT04058483 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Testing the Hypnotizability of Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which Hypnotizability testing is the first listed.

NCT04058483 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04058483 about?

NCT04058483 is a clinical study titled "Validating the New Remote Hypnotic Induction Profile (rHIP)". The purpose of the study is to determine if hypnotizability can be reliably tested over the phone, without having to see or touch a patient. The scores from a new test for hypnotizability by phone will be compared to the scores from a standard in-person test, to make sure the results are similar.

What is the current status of trial NCT04058483?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2019-09-13. Estimated completion is 2019-10-14.

What conditions does trial NCT04058483 study?

This clinical trial studies the following conditions: Testing the Hypnotizability of Healthy Volunteers.

What interventions are being tested in trial NCT04058483?

The interventions under investigation include: Hypnotizability testing (OTHER).

Who is sponsoring clinical trial NCT04058483?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04058483 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT04058483's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04058483, the US trial registry maintained by the National Library of Medicine. NCT04058483 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.